Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs ▼ | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Astellas Pharma Inc. | 1 | 0 | 0 | 0 | 9,94 € | - | - |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | 754,90 € | 824,47 € | 9,22 % |
| Sanofi S.A. ADR | 9 | 0 | 0 | 0 | 49,00 € | - | - |
| Esperion Therapeutis.Inc. | 17 | 1 | 3 | 0 | 2,23 € | 8,55 € | 282,86 % |
| MorphoSys AG | 7 | 0 | 0 | 0 | 67,70 € | 65,00 € | -3,99 % |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 0 | 0 | 74,00 € | 74,65 € | 0,87 % |
| Emergent Biosolutions Inc. | 4 | 3 | 1 | 0 | 13,00 € | - | - |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | 2,88 € | 12,21 € | 323,99 % |
| AstraZeneca plc | 2 | 0 | 0 | 0 | 143,90 € | 165,00 € | 14,66 % |
| Veracyte Inc. | 1 | 0 | 0 | 0 | 22,00 € | - | - |
| Bayer AG | 16 | 3 | 3 | 2 | 27,38 € | 45,00 € | 64,38 % |
| Knight Therapeutics | 1 | 0 | 0 | 0 | 3,72 € | 10,00 € | 168,82 % |
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | 1,38 € | 20,55 € | 1388,99 % |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | 1,73 € | 3,03 € | 75,40 % |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | 40,60 € | 50,00 € | 23,15 % |
| Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | 45,60 € | 46,37 € | 1,69 % |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | 1,26 € | 2,40 € | 90,63 % |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | 116,00 € | 124,97 € | 7,74 % |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | 16,01 € | 24,44 € | 52,67 % |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | 185,00 € | 195,00 € | 5,41 % |
| Trinity Biotech ADR | 27 | 0 | 3 | 0 | 0,41 € | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | 1,97 € | 4,00 € | 103,05 % |
| Verastem Inc. | 12 | 0 | 2 | 0 | 2,74 € | 17,56 € | 540,73 % |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | 2,36 € | 4,39 € | 86,39 % |
| Abbott Laboratories | 19 | 0 | 1 | 0 | 97,47 € | 116,25 € | 19,27 % |